Celgene (CELG) Sees Volume as CEO Hugin Tells CNBC 'No Doubt, Venture Capital Drying Up'
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Join SI Premium – FREE
Celgene (Nasdaq: CELG) shares saw a little more volume following an appearance by CEO Robert Hugin on CNBC, saying "no doubt venture capital has dried up," and "more certainty needed on healthcare reform."
Shares are slightly higher in late Thursday trading.
Shares are slightly higher in late Thursday trading.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein sees over 50% upside in this Japanese chipmaker's stock
- This consumer stock is trading at "discounted valuation", Morgan Stanley says
- Shares in this major AI chipmakers are "inexpensive": Barclays
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
